← back to search

Tianzuo Zhan

Heidelberg University · DE
Area of research
Molecular Biology · Oncology
Research interest
Research interests include CRISPR and Genetic Engineering, RNA and protein synthesis mechanisms, Colorectal Cancer Treatments and Studies, and Bacteriophages and microbial interactions.
h-index
26
citations
5,015
works
121
NIH funding
primary concept
Medicine
email

Recent publications

Digestive cancers: mechanisms, therapeutics and management
Signal Transduction and Targeted Therapy 2025cited by 44position: firstdoi
Combined MEK and PARP inhibition enhances radiation response in rectal cancer
Cell Reports Medicine 2025cited by 3position: middledoi
Structured Magnetic Resonance Imaging Assessment Improves Diagnosis of Pathological Complete Response in Rectal Cancer after Neoadjuvant Chemoradiation
Oncology Research and Treatment 2025cited by 2position: lastdoi
Clinical impact of panel gene sequencing on therapy of advanced cancers of the digestive system: a retrospective, single center study
BMC Cancer 2024cited by 3position: lastdoi
Analysis of cell free DNA to predict outcome to bevacizumab therapy in colorectal cancer patients
npj Genomic Medicine 2024cited by 2position: middledoi
Functional status and quality of life in older patients with advanced esophageal squamous cell cancer receiving second-line nivolumab ± ipilimumab therapy: A post hoc analysis of the phase 2, multicenter RAMONA study
Journal of Geriatric Oncology 2024cited by 2position: middledoi
An organoid platform reveals MEK-PARP co-targeting to enhance radiation response in rectal cancer
bioRxiv (Cold Spring Harbor Laboratory) 2024cited by 1position: middledoi
Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial
Journal of Clinical Oncology 2023cited by 189position: middledoi
The Roles of Secreted Wnt Ligands in Cancer
International Journal of Molecular Sciences 2023cited by 34position: middledoi
The drug-induced phenotypic landscape of colorectal cancer organoids
Nature Communications 2022cited by 84position: middledoi
Cross-Talk between p53 and Wnt Signaling in Cancer
Biomolecules 2022cited by 53position: lastdoi
Second-line therapy with nivolumab plus ipilimumab for older patients with oesophageal squamous cell cancer (RAMONA): a multicentre, open-label phase 2 trial
The Lancet Healthy Longevity 2022cited by 29position: middledoi
Targeting euchromatic histone lysine methyltransferases sensitizes colorectal cancer to histone deacetylase inhibitors
International Journal of Cancer 2022cited by 12position: middledoi
Personalized functional profiling using <i>ex-vivo</i> patient-derived spheroids points out the potential of an antiangiogenic treatment in a patient with a metastatic lung atypical carcinoid
Cancer Biology & Therapy 2022cited by 5position: middledoi
Sequential Geriatric Assessment in Older Patients with Colorectal Cancer during Chemotherapy: Subgroup Analysis of a Prospective, Multicenter Study EpiReal 75
Oncology Research and Treatment 2022cited by 5position: middledoi
Neglected geriatric assessment and overtreatment of older patients with pancreatic cancer - Results from a prospective phase IV clinical trial
Journal of Geriatric Oncology 2022cited by 4position: middledoi
Prognostic Cancer Gene Expression Signatures: Current Status and Challenges
Cells 2021cited by 108position: middledoi
PPARγ induces PD-L1 expression in MSS+ colorectal cancer cells
OncoImmunology 2021cited by 32position: middledoi
Pooled In Vitro and In Vivo CRISPR-Cas9 Screening Identifies Tumor Suppressors in Human Colon Organoids
Cell stem cell 2020cited by 218position: middledoi
Multi‐omics integration identifies a selective vulnerability of colorectal cancer subtypes to <scp>YM155</scp>
International Journal of Cancer 2020cited by 15position: firstdoi
Cancer-Associated Mutations in Normal Colorectal Mucosa Adjacent to Sporadic Neoplasia
Clinical and Translational Gastroenterology 2020cited by 5position: firstdoi
Cancer-associated mutations in normal colorectal mucosa adjacent to sporadic neoplasia
Zeitschrift für Gastroenterologie 2020cited by 0position: firstdoi
MEK inhibitors activate Wnt signalling and induce stem cell plasticity in colorectal cancer
Nature Communications 2019cited by 193position: firstdoi
The drug-induced phenotypic landscape of colorectal cancer organoids
bioRxiv (Cold Spring Harbor Laboratory) 2019cited by 16position: middledoi
Detection of mutational patterns in cell‐free <scp>DNA</scp> of colorectal cancer by custom amplicon sequencing
Molecular Oncology 2019cited by 11position: middledoi
Pharmacological treatment of hepatocellular carcinoma with cavoatrial tumor thrombus – case series and literature review
Zeitschrift für Gastroenterologie 2019cited by 6position: firstdoi
The effect of gender-specific invitation letters on utilization of colorectal cancer screening
Zeitschrift für Gastroenterologie 2019cited by 3position: firstdoi
MEK inhibitors activate Wnt signalling and induce stem cell plasticity in colorectal cancer
Zeitschrift für Gastroenterologie 2019cited by 2position: firstdoi
Mikroskopiebasiertes Hochdurchsatz-Wirkstoffscreening mit Organoiden zeigt wirkstoffinduzierte Phänotypen und individuelles Ansprechen
Zeitschrift für Gastroenterologie 2019cited by 0position: middledoi
CRISPR/Cas9 for cancer research and therapy
Seminars in Cancer Biology 2018cited by 317position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Johannes Betge · German Cancer Research Center28 papers (2014–2025)Michael Boutros · German Cancer Research Center23 papers (2015–2023)Sebastian Belle · University of Mannheim17 papers (2015–2025)Matthias Ebert · University of Mannheim17 papers (2015–2025)Timo Gaiser · Heidelberg University11 papers (2015–2024)Nadine Schulte · University Hospital Heidelberg11 papers (2014–2025)Thomas Hielscher · German Cancer Research Center9 papers (2014–2025)Benedikt Rauscher · Fuchs (Germany)9 papers (2017–2022)Nicolai Härtel · University Hospital Heidelberg8 papers (2014–2022)Elke Burgermeister · University Hospital Heidelberg8 papers (2019–2022)Niklas Rindtorff · Broad Institute8 papers (2016–2022)Tobias Gutting · University Hospital Heidelberg6 papers (2019–2022)Ralf Jesenofsky · University Hospital Heidelberg6 papers (2019–2022)Florian Heigwer · TH Bingen University of Applied Sciences6 papers (2015–2022)Ralf‐Dieter Hofheinz · Heidelberg University6 papers (2016–2025)Matthias P. Ebert · Heidelberg University5 papers (2016–2022) · 5 papers (2014–2019)Erica Valentini · German Cancer Research Center5 papers (2019–2022)Matthias Ebert · European Molecular Biology Organization4 papers (2018–2024)Marco Breinig · German Cancer Research Center4 papers (2015–2016)